¿Qué aporta prosigna en el tratamiento adyuvante de pacientes con cáncer de mama? - page 7

Precision from RNA
N=43 RNAs / 3 testing sites
Intrinsic subtype, 100% concordance
For ROR, 100% concordance
Site-to-site or operator-to-operator <1% of
variance
ROR SD = 0.67
Reproducibility from Tissue
N=43 FFPE / 3 testing sites
Intrinsic subtype: 97% concordance
For ROR, 90% concordance
ROR SD = 2.9
FDA 510(k)
1,2,3,4,5,6 8,9,10,11,12,13,14,15,16,17,...24
Powered by FlippingBook